Ledyard National Bank
Source: SEC Form 13F · as of Mar 2026Ledyard National Bank holds 18 biotech & pharma companies tracked by BioSniper, totaling $63.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$63.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 46,690 | $11.4M |
| AMGNAMGEN INC | 26,197 | $9.2M |
| MRKMerck & Co., Inc. | 73,445 | $8.8M |
| PFEPFIZER INC | 182,630 | $5.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 6,226 | $4.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 17,377 | $4.7M |
| LLYELI LILLY & Co | 4,871 | $4.5M |
| ABBVAbbVie Inc. | 17,853 | $3.9M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 49,944 | $2.8M |
| CORCencora Inc. | 8,772 | $2.8M |
| UTHRUNITED THERAPEUTICS Corp | 2,820 | $1.7M |
| ABTABBOTT LABORATORIES | 14,802 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 17,249 | $1.0M |
| PMPhilip Morris International Inc | 3,745 | $619K |
| IDXXIDEXX LABORATORIES INC /DE | 661 | $371K |
| SNYSanofi | 4,881 | $235K |
| NVSNovartis AG | 1,417 | $216K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 457 | $204K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.